Advertisement

Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase

Published:August 12, 2022DOI:https://doi.org/10.1016/j.jacl.2022.08.002

      Highlights

      • Phenotypic description of family members with primary hyperalphalipoproteinemia.
      • Identification of a novel likely pathogenic variant of LIPG in three subjects.
      • Large HDL particles and reduced preβ-HDL content found in variant carriers.
      • Decreased ABCA1- and ABCG1-mediated cholesterol efflux capacity of carriers’ sera Increased cholesterol loading capacity of carriers’ sera in human macrophages.

      Background

      Loss of function variants of LIPG gene encoding endothelial lipase (EL) are associated with primary hyperalphalipoproteinemia (HALP), a lipid disorder characterized by elevated plasma levels of high density lipoprotein cholesterol (HDL-C).

      Objective

      Aim of the study was the phenotypic and genotypic characterization of a family with primary HALP.

      Methods

      HDL subclasses distribution was determined by polyacrylamide gradient gel electrophoresis. Serum content of preβ-HDL was assessed by (2D)-electrophoresis. Cholesterol efflux capacity (CEC) of serum mediated by ABCA1, ABCG1 or SR-BI was assessed using cells expressing these proteins. Cholesterol loading capacity (CLC) of serum was assayed using cultured human macrophages. Next generation sequencing was used for DNA analysis. Plasma EL mass was determined by ELISA.

      Results

      Three family members had elevated plasma HDL-C, apoA-I and total phospholipids, as well as a reduced content of preβ-HDL. These subjects were heterozygous carriers of a novel variant of LIPG gene [c.526 G>T, p.(Gly176Trp)] found to be deleterious in silico. Plasma EL mass in carriers was lower than in controls. CEC of sera mediated by ABCA1 and ABCG1 transporters was substantially reduced in the carriers. This effect was maintained after correction for serum HDL concentration. The sera of carriers were found to have a higher CLC in cultured human macrophages than control sera.

      Conclusion

      The novel p.(Gly176Trp) variant of endothelial lipase is associated with changes in HDL composition and subclass distribution as well as with functional changes affecting cholesterol efflux capacity of serum which suggest a defect in the early steps of revere cholesterol transport.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zhou H
        • Gong Y
        • Wu Q
        • et al.
        Rare disease related with lipoprotein metabolism.
        Adv Exp Med Biol. 2020; 1276: 171-188https://doi.org/10.1007/978-981-15-6082-8_11
        • Yamashita S
        • Maruyama T
        • Hirano KI
        • et al.
        Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
        Atherosclerosis. 2000; 152: 271-285https://doi.org/10.1016/s0021-9150(00)00574-8
        • Voight BF
        • Peloso GM
        • Orho-Melander M
        • et al.
        Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomization study.
        Lancet. 2012; 380: 572-580https://doi.org/10.1016/S0140-6736(12)60312-2
        • Giammanco A
        • Noto D
        • Barbagallo CM
        • et al.
        Hyperalphalipoproteinemia and beyond: the role of HDL in Cardiovascular diseases.
        Life. 2021; 11: 581https://doi.org/10.3390/life11060581
        • Franceschini G.
        Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease.
        Am J Cardiol. 2001; 88: 9N-13Nhttps://doi.org/10.1016/s0002-9149(01)02146-4
        • Rader DJ
        • Jaye M
        Endothelial lipase: a new member of the triglyceride lipase gene family.
        Curr Opin Lipidol. 2000; 11: 141-147https://doi.org/10.1097/00041433-200004000-00006
        • Jahangori A
        • Rader DJ
        • Marchadier D
        • et al.
        Evidence that endothelial lipase remodels high density lipoproteins without mediating dissociation of apolipoprotein A-I.
        J Lipid Res. 2005; 46: 896-903https://doi.org/10.1194/jlr.M400212-JLR200
        • Griffon N
        • Jin W
        • Petty TJ
        • et al.
        Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation.
        J Biol Chem. 2009; 284: 23322-23330https://doi.org/10.1074/jbc.M109.037002
        • Brown RJ
        • Edmondson AC
        • Griggon N
        • et al.
        A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis.
        J Lipid Res. 2009; 50: 1910-1916https://doi.org/10.1194/jlr.P900020-JLR200
        • Edmondson AC
        • Brown RJ
        • Kathiresan S
        • et al.
        Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.
        J Clin Invest. 2009; 119: 1042-1050https://doi.org/10.1172/JCI37176
        • Singaraja RR
        • Sivapalaratnam S
        • Hovingh K
        • et al.
        The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans.
        Circ Cardiovasc Genet. 2013; 6: 54-62https://doi.org/10.1161/CIRCGENETICS.111.962613
        • Cole J
        • Blackhurst DM
        • Solomon GAE
        • et al.
        Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants.
        J Clin Lipidol. 2021; 15: 142-150https://doi.org/10.1016/j.jacl.2020.12.007
        • Ossoli A
        • Simonelli S
        • Varrenti M
        • et al.
        Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) rescues defective HDL (High-Density Lipoprotein)-mediated endothelial protection in acute coronary syndrome.
        Arterioscler Thromb Vasc Biol. 2019; 39: 915-924https://doi.org/10.1161/ATVBAHA.118.311987
        • Calabresi L
        • Pisciotta L
        • Costantin A
        • et al.
        The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
        Arterioscler Thromb Vasc Biol. 2005; 25: 1972-1978https://doi.org/10.1161/01.ATV.0000175751.30616.13
        • Ossoli A
        • Strazzella A
        • Rottoli D
        • et al.
        CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
        Metabolism Clin Exp. 2021; 116154464https://doi.org/10.1016/j.metabol.2020.154464
        • Franceschini G
        • Calabresi L
        • Colombo C
        • et al.
        Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients.
        Atherosclerosis. 2007; 195: 385-391https://doi.org/10.1016/j.atherosclerosis.2006.10.017
        • Rabacchi C
        • Simone ML
        • Pisciotta L
        • et al.
        In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia.
        J Clin Lipidol. 2019; 13: 960-969https://doi.org/10.1016/j.Jacl.2019.09.003
        • den Dunnet JT
        • Dalgleish R
        • Maglott DR
        • et al.
        HGVS recommendations for the description of sequence variants: 2016 Update.
        Hum Mutat. 2016; 37: 564-569https://doi.org/10.1002/humu.2298
        • Favari E
        • Chroni A
        • Tietge UJ
        • et al.
        Cholesterol efflux and reverse cholesterol transport.
        Handb Exp Pharmacol. 2015; 224: 181-206https://doi.org/10.1007/978-3-319-09665-0_4
        • Vigna GB
        • Satta E
        • Bernini F
        • et al.
        Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia.
        Nutr Metab Cardiovasc Dis. 2014; 24: 777-783https://doi.org/10.1016/j.numecd.2014.02.010
        • Favari E
        • Thomas MJ
        • Sorci-Thomas MG.
        High-density lipoprotein functionality as a new pharmacological target on cardiovascular disease: unifying mechanism that explains high-density lipoprotein protection toward the progression of atherosclerosis.
        J Cardiovasc Pharmacol. 2018; 71: 325-331https://doi.org/10.1097/FJC.0000000000000573
        • Zimetti F.
        • Weibel G.K.
        • Duong M.
        • Rothblat G.H.
        Measurement of cholesterol bidirectional flux between cells and lipoproteins.
        J Lipid Res. 2006; 47: 605-613https://doi.org/10.1194/jlr.M500466-JLR200
        • Razzaghi H
        • Tempczyk-Russell A
        • Haubold K
        • et al.
        Genetic and structure-function studies of missense mutations in human Endothelial Lipase.
        PLOS one. 2013; 8: e55716https://doi.org/10.1371/journal.pone.0055716
        • Annema W
        • Tietge UJF.
        Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.
        Curr Atheroscler Rep. 2011; 13: 257-265https://doi.org/10.1007/s11883-011-0175-2
        • Broedl UC
        • Maugeais C
        • Millar JS
        • et al.
        Endothelial lipase Promotes the catabolism of apoB-containing lipoproteins.
        Circ Res. 2004; 94: 1554-1561https://doi.org/10.1161/01.RES.0000130657.00222.39
        • Khetarpal SA
        • Vitali C
        • Levin MG
        • et al.
        Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
        PLOS Genet. 2021; 17e1009802https://doi.org/10.1371/journal.pgen.1009802
        • Ma K
        • Forte T
        • Otvos JD
        • Chan L.
        Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse model.
        Arterioscler Thromb Vasc Biol. 2005; 25: 149-154https://doi.org/10.1161/01ATV.0000150414.89591.6a
        • Nijstad N
        • Wiersma H
        • Gautier T
        • et al.
        Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase.
        J Biol Chem. 2009; 284: 6093-6100https://doi.org/10.1074/jbc.M807683200
        • Phillips MC.
        Molecular mechanisms of cellular cholesterol efflux.
        J Biol Chem. 2014; 289: 24020-24029https://doi.org/10.1074/jbc.R114.583658
        • Camont L
        • Lhomme M
        • Rached F
        • et al.
        Small, dense High-Density Lipoprotein-3 particles are enriched in negatively charged phospholipids. Relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
        Arterioscler Thromb Vasc Biol. 2013; 33: 2715-2723https://doi.org/10.1161/ATVBAHA.113.301468
        • Ruff CT
        • Koren MJ
        • Grimsby J
        • et al.
        LEGACY: phase 2a trial to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of the anti-EL (Endothelial Lipase) antibody MEDI5884 in patients with stable coronary artery disease.
        Arterioscler Thromb Vasc Biol. 2021; 41: 3005-3014https://doi.org/10.1161/ATVBAHA.120.315757
        • Yancey PG
        • Kawashiri M
        • Moore R
        • et al.
        In vivo modulation of HDL phospholipid has opposing effect on SR-BI- and ABCA1-mediated cholesterol efflux.
        J Lipid Res. 2004; 45: 337-346https://doi.org/10.1194/jlr.M300231-JLR200
        • Qui G
        • Hill JS.
        Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages.
        Arterioscler Thromb Vasc Biol. 2009; 29: 84-91https://doi.org/10.1161/ATVB.AHA.108.176487
        • Rohatgi A
        • Khera A
        • Berry JD
        • et al.
        HDL Cholesterol Efflux Capacity and incident cardiovascular events.
        New Engl J Med. 2014; 371: 2383-2393https://doi.org/10.1056/NEJMoa1409065
        • Qiu C
        • Zhao X
        • Zhou Q
        • Zhang Z.
        High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis.
        Lipids Health Dis. 2017; 16: 212https://doi.org/10.1186/s12944-017-0604-5